Skip to main content

Nifty flat, but decliners ran 2.4-to-1 — this is not a dip

Yesterday's bounce gave back its internals in one session. The tape is deteriorating, not consolidating.

Tuesday, 28 July 20262 min readStage2Stocks Market Desk

Nifty 50
23,985
0% on the day
Market
Neutral — Fading
4 sessions in this state
Breadth
41%
above 200-DMA · narrow
Adv / Dec
642 / 1,565
decliners ahead
52w highs / lows
132 / 107
net +25
Stage-2 share
34%
cohort narrowing

Yesterday's 1% bounce was a one-day reprieve, not a turn. Today Nifty closed flat at 23,985 while decliners swamped advancers 1,565 to 642 — the index held, the market did not. The trajectory is a broad decline, and the screen's setups exist because the screener runs every day, not because the backdrop supports them.

The internals say deterioration, not consolidation

The slow structural gauge — the share of stocks above their 200-day average — has slid from 43.8% six sessions ago to 41.4% today, a steady bleed that confirms this is not a routine pullback inside an uptrend. The fast short-term gauge, stocks above their 20-day average, collapsed from 43.6% on 21 July to 34.1% today, with Monday's bounce to 39.1% entirely reversed in a single session. Net new highs tell the same story: 86 on 21 July, down to a negative reading on 23 July, and only 25 today despite a flat index — the leadership pool is shrinking. Sixty-four stocks dropped from Stage 2 to Stage 3 against just 28 moving the other way over the last five days; the advancing cohort is narrowing, not widening.

Leadership is narrow and concentrated in two sectors

Real Estate and Information Technology led on the day, up 2.1% and 2.0% respectively, and both are where the Stage-2 cohort has been expanding fastest over the last 20 days — they are the only pockets of genuine structural momentum right now. Health Care holds the strongest Stage-2 participation at over 50% of its stocks in the advancing stage, and names like Wanbury Ltd have cleared the screen with high setup scores, but Health Care clearing screens in a deteriorating tape is context, not a signal to act. With only 41% of the broader market above their 200-day average and the Nifty itself sitting below that level, the weight of evidence is against new setups following through.

Leading Stage-2 setups
StockSectorSetup% 1D
Wanbury LtdHealth Care9.4-5.1%
Sky Gold and Diamonds LtdConsumer Discretionary9.4-0.5%
Kabra Extrusion Technik LtdIndustrials9.4-1.4%
Cyient DLM LtdIndustrials9.2+2.5%
RPG Life Sciences LtdHealth Care9.0-1.3%
Kapston Services LtdIndustrials9.0-2.2%
Filatex India LtdConsumer Discretionary9.0-2.3%
Steel Strips Wheels LtdConsumer Discretionary9.0+0.3%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Real Estate+2.1%+12.2%+16.0%5323%
Information Technology+2.0%+9.2%+3.4%4731%
Communication Services+0.5%+4.1%+9.2%6520%
Consumer Discretionary+0.1%+4.7%+5.9%6936%
Health Care-0.1%+3.2%+14.2%7450%
Financials-0.4%-0.7%-1.6%6234%
Energy-0.6%-0.2%-4.6%5729%
Materials-0.7%+1.0%+0.0%6932%
Industrials-0.7%-2.0%+5.7%7037%
Consumer Staples-1.3%+0.1%-2.7%5424%
Utilities-1.8%-3.6%-4.5%6221%
Share of NSE stocks in Stage 2Feb 2026 – Jul 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 34%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →